Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World DataGuofeng Chen, George Lau, Lai Wei et al.|PLoS ONE|2016Cited by 44
Hantaan Virus Infection Induces CXCL10 Expression through TLR3, RIG-I, and MDA-5 Pathways Correlated with the Disease SeverityYusi Zhang, Boquan Jin, Kun Yang et al.|Mediators of Inflammation|2014Cited by 34
Interferon-α-Enhanced CD100/Plexin-B1/B2 Interactions Promote Natural Killer Cell Functions in Patients with Chronic Hepatitis C Virus InfectionYu He, Jia Zhansheng, Yonghong Guo et al.|Frontiers in Immunology|2017Cited by 17
Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agentsTaotao Yan, Yingli He, Jiuping Wang et al.|BMC Infectious Diseases|2019Cited by 3